How can the EU’s pharmaceutical legislation help tackle current challenges, including medicine shortages and antimicrobial resistance, across Europe? We put the question to Rainer Becker, Director for Medical Products and Innovation at DG SANTE.
Magnus Heunicke, Minister for Health at the Danish Ministry of Health, argues that one size doesn’t fit all when it comes to Denmark moving towards personalised medicine.
Prof Masahiro Kamitani from the Department of Chemistry at Kitasato University, Japan, introduces recent advances in the development of catalysts for organic synthesis and iron catalysts as alternatives for precious metal catalysts.
Roxane Feller, AnimalhealthEurope Secretary-General, tells us all about the new EU rules on veterinary medicines to support more responsible use of antibiotics.
The U.S. Food and Drug Administration (FDA) has given authorisation for the Pfizer/BioNTech COVID-19 booster vaccine to be administered to people aged 65 and over.
Arun Swaminathan MD, Assistant Professor of Neurology and Epilepsy at the University of Nebraska Medical Center, details the expanding scope of cannabinoids in epilepsy.
Rick Clayton, Technical Director, AnimalhealthEurope, in the final chapter of this three-part series, examines the benefits of benchmarking regulatory systems and promoting Good Regulatory Practice.
